Thermo Fisher Scientific Inc (NYSE:TMO) traded higher in the last at $152.04, gaining 0.39 points or 0.26%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-3.41) million. The composite uptick value of $2.91 million was eclipsed by the accrued downtick value of $6.32 million, thereby ensuring the up/down ratio of 0.46. For the week, the shares have posted returns of -0.54%.A block trade registered during the day has revealed $0 million in upticks and $2.34 million in downticks. The up/down ratio in this case turned out to be 0. The net money flow for the block trade was $(-2.34) million.
Currently the company Insiders own 0.52% of Thermo Fisher Scientific Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -7.47% . Institutional Investors own 90.92% of Thermo Fisher Scientific Inc shares. During last six month period, the net percent change held by insiders has seen a change of -8.52%. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Manzi Jim P, director of Thermo Fisher Scientific Inc., had unloaded 1,137 shares at an average price of $153 in a transaction dated on June 3, 2016. The total value of the transaction was worth $173,961.
Thermo Fisher Scientific Inc (NYSE:TMO) stock ended Monday session in the red zone in a volatile trading. The stock closed down 1.13 points or 0.75% at $150.52 with 956,772 shares getting traded. Post opening the session at $151.5, the shares hit an intraday low of $150.44 and an intraday high of $152.34 and the price was in this range throughout the day. The company has a market cap of $59,231 million and the number of outstanding shares have been calculated to be 393,512,230 shares. The 52-week high of Thermo Fisher Scientific Inc (NYSE:TMO) is $154.81 and the 52-week low is $117.1.
Many analysts have stated their opinion on the company shares. Jefferies downgrades its view on Thermo Fisher Scientific Inc (NYSE:TMO) according to the research report released by the firm to its investors. The shares have now been rated Hold by the stock experts at the ratings house. Earlier, the shares had a rating of Buy. The rating by the firm was issued on April 29, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.